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Abstract Methicillin-resistant Staphylococcus aureus
(MRSA) strains from different geographic areas have dif-
ferent genetic backgrounds, suggesting independent clonal
evolutions. To better understand the virulence of MRSA
strains and the relationship to their clonal and geographic
origins, we undertook an analysis of epidemiologic, molec-
ular, and virulence characteristics of a large number of
MRSA isolates from geographically diverse origins, in a
Caenorhabditis elegans infection model. A total of 99
MRSA isolates collected between 1993 and 2010 at the
Geneva University Hospitals from diverse global origins
were characterized with Panton–Valentine leukocidin
(PVL), toxic shock syndrome toxin (TSST), accessory gene
regulator (agr) group, staphylococcal cassette chromosome
mec (SCCmec), S. aureus protein A (spa), multilocus se-
quence typing (MLST), and pulsed-field gel electrophoresis
(PFGE) typing. Epidemiologic data were provided from
clinical records. The bacterial virulence was tested in a C.
elegans host model. The inter-relationships of epidemiolog-
ical/molecular characteristics in association with nematoci-
dal activities were analyzed with univariate and two-factor
analysis of variance (ANOVA). Community-associated
MRSA (CA-MRSA) strains were more virulent than
hospital-associated MRSA (HA-MRSA), with higher nem-
atocidal activities in CA-MRSA strains (0.776 vs. 0.506, p0
0.0005). All molecular characteristics (PVL, TSST, spa,
SCCmec, MLST, and PFGE types) showed a significant
association with nematocidal activities on univariate
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analysis (p<0.005). PVL was not a significant predictor
after adjusting for genomic backgrounds using spa, MLST,
or PFGE typing. The dominant CA-MRSA strains in North
America showed higher nematocidal activities than strains
from other regions (p<0.0001). Strains with global origins
containing distinct genetic backgrounds have different viru-
lence in the C. elegans model. Nematocidal activities were
most highly correlated with SCCmec, spa, MLST, and
PFGE typing, suggesting that genomic background rather
than a single exotoxin characteristic was the most discrim-
inating predictor of virulence.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) infec-
tions have been reported in the hospital and community
settings worldwide since the first case was identified in the
United Kingdom [1]. With the evolving epidemiology and
development in molecular typing methods for S. aureus, it
has become possible to study the population and evolution-
ary biology of MRSA on a larger geographic level. Based on
multilocus sequence typing (MLST), there are currently 17
major clonal complexes (CCs) identified from the S. aureus
isolates collected worldwide, including methicillin-
susceptible S. aureus (MSSA) and MRSA strains [2]. For
hospital-associated MRSA (HA-MRSA), the Iberian
(ST247), Brazilian (ST239), Paediatric (ST5), EMRSA15
(ST22), EMRSA16 (ST36), and Berlin (ST45) clones are
recognized pandemic clones in the world [3]. However,
community-associated MRSA (CA-MRSA) have different
patterns, with the major CA-MRSA clones being ST1, ST8,
ST30, ST59, ST80, and ST88, plus other minor clones,
circulating around the world [4–6]. ST1 and ST8 CA-
MRSA, also named as USA400 and USA300, respectively,
are two dominant CA-MRSA strains in North America.
ST30, ST59, ST80, and ST88 are successful CA-MRSA
strains present in Australia, Taiwan, Europe, and Africa,
respectively [7, 8].
The reason for the distinct epidemiologic patterns of
MRSA clones in different geographic areas is unknown.
Previous studies have shown that strain ST8 has enhanced
virulence in human infection and animal models, which may
contribute to its dominance in North America [9–12]. How-
ever, whether there are differences in virulence between the
strains circulating in the community in different continents,
such as ST8, ST80, or ST30 strains, has not been fully
investigated.
We have previously shown that CA-MRSA is more vir-
ulent than HA-MRSA using an invertebrate Caenorhabditis
elegans host model, correlating the findings with human
clinical data [13]. In an effort to better understand the
virulence of MRSA strains and their relationship to their
clonal and geographic origins, we analyzed the bacterial
virulence of a large number of MRSA isolates from geo-
graphically diverse origins using a C. elegans infection
model, and undertook a detailed epidemiologic, molecular,
and virulence correlative analysis of these isolates.
Materials and methods
Bacterial strains and isolates
A total of 99 isolates, during a 17-year period (1993–2010),
were obtained from retrospective specimen collections , the
details of which are described elsewhere [7, 14], in the
Geneva University Hospitals, a 2,200-bed primary and ter-
tiary medical center in Switzerland These isolates were
obtained from the original stocks which had been retained
in the freezer over the years. The isolates were separated
into different categories based on their clinical sites, includ-
ing colonization, skin and soft tissue infection (SSTI), pul-
monary infection, mastitis, urinary tract infection, otitis
externa, septic arthritis, and bloodstream infection. These
isolates were also separated into hospital-associated and
community-associated strains based on the presence of the
infection or colonization within 48 h after hospital admis-
sion. Reference strains CMRSA1–10 and USA100–1000
were provided by the National Microbiology Laboratory
(NML), Health Canada (Winnipeg, Manitoba, Canada),
and by the Network on Antimicrobial Resistance in Staph-
ylococcus aureus (NARSA), respectively.
Molecular and genomic characterization of isolates
Genomic DNA isolated from a single colony was tested
by multiplex real-time polymerase chain reaction (PCR)
for staphylococcal cassette chromosome mec (SCCmec)
elements, accessory gene regulator (agr) group, Panton–
Valentine leukocidin (PVL), and toxic shock syndrome
toxin-1 (TSST) [7]. The presence of arginine deiminase
(arcA) was assessed by PCR-based assays (arcA-F:
GCAGCAGAATCTATTACTGAGCC ; a rcA-R :
TGCTAACTTTTCTATTGCTTGAGC). MLST typing and
pulsed-field gel electrophoresis (PFGE) were performed as
previously reported [15, 16]. PFGE clusters were defined
according to the criteria described by Tenover et al. [17].
C. elegans survival assay
The virulence of all 98 isolates (one isolate forming a thick
bacterial lawn was excluded) was tested in triplicate, using a
C. elegans host model, with the strains NCTC8325 and M92
representing positive and negative reference strains, respec-
tively [13]. Briefly, Bristol N2C. elegans nematodes were
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maintained at room temperature (RT) on nematode growth
medium (NGM) plates seeded with Escherichia coli strain
OP50 as a food source. A 10-μl aliquot of 10× diluted
overnight culture of S. aureus in brain–heart infusion
(BHI) broth was spread into 3.5-cm-diameter plates contain-
ing tryptic soy agar (TSA) supplemented with 5 μg/ml
nalidixic acid (NA) and incubated at 37 °C for 4–6 h. Thirty
4th larval (L4) stage hermaphrodite nematodes were trans-
ferred from E. coli OP50 NGM plates to the assay TSA
plates grown with the tested isolates, and the plates were
kept at RT. Their survival was monitored every 24 h over a
5-day period. Data were analyzed by the Kaplan–Meier
method for nematode survival rate using GraphPad Prism
(GraphPad Software, La Jolla, CA, USA). To compare the
nematocidal activities from each individual experiment, all
the nematocidal activities were calibrated with the positive
reference strain (nematocidal activity referenced as 1) and
the negative reference strain (nematocidal activity
referenced as 0). The calibrated death rate, representing the
mean of the triplicate testing, was calculated as Δdeath rate
(test strain-M92)/Δdeath rate (NCTC8325-M92).
Statistical methods
Student’s t-test and the single-factor analysis of variance
(ANOVA) test were used to determine whether the
epidemiological or molecular characteristics, including
community/hospital association, pvl, tsst-1, agr, ST,
PFGE, or spa types, were associated with bacterial
virulence based on the calibrated nematocidal activity.
Two-factor ANOVA testing (SPSS v15, IBM, USA) was
used to investigate the inter-relationships between char-
acteristics found to be significant in the univariate anal-
ysis using a level of significance of 0.05. Isolates were
excluded from the analysis if they fell into a group
containing less than three isolates.
Results
Epidemiology of Geneva isolates
A total of 99 isolates were collected from 99 patients [mean
± standard deviation [SD] age: 36±25 years] travelling from
or living in different continents, including Europe, North
America, South America, Africa, Asia, and Australia
(Fig. 1). Of the total number of isolates, 40 were hospital-
associated, 47 were community-associated, and 12 had un-
known origins (Table 1). Almost half of the isolates were
identified as colonizing isolates and 36 isolates were associated
with SSTI. Nine isolates were associated with other infections,
including bloodstream infection, septic arthritis, urinary tract
infection, mastitis, otitis externa, and tracheobronchitis. The
cases of otitis externa and tracheobronchitis may be considered
less invasive than the other infections. The clinical manifesta-
tions associated with the remaining nine isolates were un-
known. When these isolates were grouped into colonization
and infection isolates (Table 1), the relative ratios of coloniza-
tion versus infection for the community-associated (16/31,
0.52) and the hospital-associated (26/14, 1.86) isolates, respec-
tively, were significantly different from each other (p00.0064
by the χ2 test).
Molecular characteristics of Geneva isolates
There were 39 spa, 19 ST, and 26 PFGE types (one isolate
untypable) identified among the 99 isolates (Fig. 1). All
isolates were resistant to methicillin, and carried type I, II,
III, IV, V, or VI SCCmec elements, except for two isolates,
both of which contained mecA, but were unable to be typed
with the available methodology. The PVL gene was only
found in SCCmec IV and V isolates. Moreover, the majority
of these isolates belonged to agr I, II, or III, with only one
isolate carrying agr IV (Fig. 1).
MLST showed that ST1, ST5, ST8, ST30, ST80, ST85,
and ST88 were the major ST groups with more than five
isolates. ST8-SCCmec IV isolates were clustered with the
USA300 reference strain, and carried arcA, which is located
in a unique mobile genetic element (arginine catabolic mo-
bile element, ACME), whereas ST1-SCCmec IV isolates
were clustered with the USA400 reference strain. All ST1,
ST8, ST30, and ST80 carried SCCmec IV, except for one
ST8 isolate which carried SCCmec I and two ST30 isolates
which carried SCCmec V; in contrast, ST85 and ST5 carried
more diversified SCCmec elements, such as SCCmec I, II,
IV, and V.
Both ST8-SCCmec IV and ST1-SCCmec IV isolates in
this collection originated from countries other than North
America, such as South America and South East Asia.
Strains of ST80 also originated from countries in Northern
Africa, in addition to central Europe.
Correlation between epidemiological/molecular
characteristics and nematocidal activities
The virulence of 98 isolates (one isolate could not be reli-
ably tested in the assay) in the C. elegans host model was
shown as the calibrated death (CD) (Fig. 1). To determine
which epidemiological or molecular characteristics were
associated with the nematocidal activity in the C. elegans
model, different comparisons were made among groups
carrying the same characteristic.
There was no significant difference in the mean nemato-
cidal activity in those isolates associated with clinical infec-
tion versus those associated with colonization. However,
isolates which originated from the community showed
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Fig. 1 Global origins and
molecular features of Geneva
isolates. USA100–800 and
CMRSA1–10 were used as
reference strains, highlighted in
gray and dark gray,
respectively. arcA, arginine
deiminase of arginine catabolic
mobile element (ACME) from
USA300; PVL, Panton–Valen-
tine leukocidin; TSST, toxic
shock syndrome toxin; agr, ac-
cessory gene regulator;
SCCmec, staphylococcal cas-
sette chromosomal mec; spa,
Staphylococcus aureus protein
A; ST, sequence type; calibrat-
ed death, the nematocidal ac-
tivity of Geneva isolates
normalized with positive and
negative control strains in the
Caenorhabditis elegans model.
One strain was nontypable by
pulsed-field gel electrophoresis
(PFGE); two strains were
untypable using the available
SCCmec typing method and
one strain (#18) could not be
reliably tested in the C. elegans
model
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significantly higher nematocidal activities than isolates from
the hospital (mean CD: 0.776 vs. 0.506, p00.0005, Fig. 2a).
This result correlated with the clinical outcomes, with more
isolates from the community causing infections than those
from the hospital (Table 1). The comparison between pvl+
and pvl− isolates showed that pvl+isolates had higher nem-
atocidal activities than pvl− isolates (mean CD: 0.815 vs.
0.601, p00.0053, Fig. 2b). Unexpectedly, the comparison
between tsst-1+ and tsst-1− isolates showed that tsst-1−
isolates had significantly higher nematocidal activities than
tsst-1+ isolates (mean CD: 0.766 vs. 0.299, p<0.0001,
Fig. 2c).
Single-factor ANOVA was used to determine whether
different agr, SCCmec, spa, ST, or PFGE types were asso-
ciated with nematocidal activities. For agr types, the mean
CD of nematocidal activities of agr I was 0.816, agr II
0.524, and agr III 0.717 (F05.57, p00.005; Fig. 2d), re-
spectively. For SCCmec types, SCCmec IV showed higher
virulence than the other SCCmec types (F09.54, p<0.0001;
Fig. 2e). Similarly, the spa type t008 showed a greater mean
CD than the other groups, excluding the groups with less
than two isolates (F02.29, p00.013; Fig. 2f). Moreover,
CA-MRSA strains ST8 and ST1 were significantly more
virulent than prevalent strains in other geographic areas,
including ST88, ST80, ST85, ST30, and ST5, with the mean
CD of ST8 isolates, 1.13, being the greatest (F06.61, p<
0.0001; Fig. 2g). Furthermore, the PFGE cluster 2,
corresponding to ST8 and spa t008 isolates, had a greater
mean CD than the other clusters (F02.67, p00.001;
Fig. 2h).
Two-factor ANOVA was employed to investigate the
inter-relationship of these epidemiological or molecular
factors to determine which factor was an independent
factor for predicting bacterial virulence. As shown in
Fig. 3a–f, when isolates were divided into groups of
community/hospital or different agr, SCCmec, spa, ST,
and PFGE types, the nematocidal activities of pvl+and
pvl− isolates inside each group were not significantly
different from each other, except for agr types. On the
other hand, TSST showed a negative correlation with
the nematocidal activities and two-factor ANOVA
showed that this impact was independent from other
factors, except the ST type (Fig. 3g–l).
Moreover, as shown in Table 2, the factor community/
hospital appeared to interact with other molecular factors,
including agr, spa, and PFGE (F<2.357, p00.07); and agr
was a dependent factor related to SCCmec, ST, PFGE, and
spa types (F<1.346, p00.265). However, SCCmec, ST,
PFGE, and spa types were independent factors more directly
associated with nematocidal activities (F>1.614, p00.052),
except that ST and PFGE appear to be co-dependent
(F<1.848, p00.071) (Table 2).
Discussion
In this study, we utilized the C. elegans host model to
investigate the pathogenic mechanisms of different
MRSA clones from different geographic regions world-
wide. ST8 and ST1 strains, the dominant CA-MRSA
strains for North America, showed significantly higher
virulence than ST5, ST30, ST80, and ST88 strains, the
prevalent CA-MRSA strains in other geographic areas.
This result may suggest a competitive advantage for
these strains and provides a possible explanation for
the unequal dissemination of these strains across North
America and the increasing prevalence in some Europe-
an countries [18, 19]. It is possible that bacterial viru-
lence may be related to fitness in the environment,
promoting the enhanced transmissibility of these strains
[20]. The ST80 and ST88 strains, showing higher nem-
atocidal activities than the ST5 and ST30 strains, are
dominant CA-MRSA strains in central Europe and
Africa [6–8, 18, 21]. Recently, DeLeo et al. showed
that a historically pandemic MSSA clone, phage-type
80/81, causing infections in hospitals as well as outside
of the healthcare setting, was highly virulent in mouse
infection models compared with other genetically related
clones that were mostly hospital-associated infections,
supporting the suggestion that high bacterial virulence
contributes to increased transmissibility [22].
However, low bacterial virulence does not necessarily
correlate with low prevalence. As shown in our study,
the ST30 strain exhibited a relatively low nematocidal
activity, but is a dominant CA-MRSA clone in Oceania
and the Southwest Pacific [5]. It is possible that CA-
MRSA strains originate independently in different
Table 1 Epidemiologic profiles of 99 isolates collected in Geneva
University Hospitals, 1993–2010, stratified by their origin (community
vs. hospital)
Clinical sites Community Hospital Unknown
source
Colonization 16 26 3








Total 47 40 12
SSTI, skin and soft tissue infection; UTI, urinary tract infection
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geographic areas, and strains with certain genomic fea-
tures may have become endemic within their originating
areas, but may have lower virulence than CA-MRSA
strains endemic in other areas. Human or animal travel
may have promoted the spread of endemic CA-MRSA
strains across continents, with the dominant North
American CA-MRSA strain ST8 having been isolated
now in Europe and Asia [6, 23–25]. Why ST80 has
remained a dominant clone within Europe and Northern
Africa, despite the entry of the ST8 strain, is unknown.
The presence of ST80 may provide a relative protection
from the entry of another strain on a population basis or
it may only be a matter of time until the ST8 strain
becomes dominant in Europe.






















































































































































































































































































Fig. 2 Correlation between different epidemiologic/molecular charac-
teristics and nematocidal activities. The nematocidal activity correlated
with different epidemiologic/molecular characteristics: a community
vs. hospital; b pvl; c tsst-1; d agr type; e SCCmec types; f spa type; g
ST type; h PFGE cluster. The numbers in brackets or on top of bars
indicate the number of isolates analyzed in the group
Fig. 3 Two-factor analysis of variance (ANOVA) to determine the
inter-relationship of PVL or TSST with other epidemiologic/molecular
characteristics in association with nematocidal activities. a–f The im-
pact of PVL on nematocidal activities is dependent on: a community
vs. hospital; b agr type; c SCCmec type; d spa type; e ST type; and f
PFGE cluster. g–l The impact of TSST on nematocidal activities is
independent of: g community vs. hospital; h agr type; i SCCmec type;
j spa type; k ST type; and l PFGE cluster
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This study also determined which molecular markers
would be more reliable predictors for bacterial virulence.
Currently, the role of PVL in bacterial pathogenesis is still
controversial [26–28]. In the present study, PVL was a
dependent factor related to other molecular markers, such
as agr, SCCmec, ST, PFGE, and spa types. For example,
with the same ST types, pvl+ and pvl− isolates had similar
nematocidal activities, suggesting that PVL alone may not
contribute to nematocidal activities. In contrast, the presence
of the tsst-1 gene was associated with less nematocidal
activity in the C. elegans model, with tsst-1+ isolates dem-
onstrating less virulence than tsst-1− isolates. TSST is a
superantigen stimulating the release of large amounts of
proinflammatory factors in human infection, and has been
associated with human toxic shock syndrome, which affect-
ed menstruating women who were using tampons [29], and
it may not be necessary for bacterial virulence in inverte-
brates that only have innate immunity [30]. Alternatively,
the tsst-1 gene in this study is mostly associated with the
isolates with ST5, ST30, and ST149, which have low nem-
atocidal activity (Figs. 1 and 3g). However two-factor
ANOVA showed that, with the same ST type, the CDs of
tsst-1+ and tsst-1− isolates were not significantly different,
suggesting that the presence of TSST is less correlated with
nematocidal activities when the total genomic background is
considered (Fig. 3k). The virulence of these isolates appears
to be associated with typing methods that correlate with
strain differentiation at the genomic level, represented by
spa, ST, or PFGE types, rather than by toxins produced by a
single virulence gene, such as pvl or tsst-1. Therefore, the
molecular markers, spa, ST, or PFGE types were the most
discriminating predictors of virulence in our C. elegans
model.
Moreover, the data from the C. elegans model and the
clinical data were relatively well correlated. Isolates from
the community, exhibiting higher nematocidal activities
than those from the hospital, were more associated with
infection than colonization. These findings are corroborated
by a previous study [13] and further validates that the C.
elegans model is a useful tool to study the virulence of S.
aureus.
We acknowledge the limitations in our study. We recog-
nize that it is difficult to validate the geographic origins of
these organisms, but given the propensity for long-term
carriage of MRSA strains, the lack of exogenous cross-
transmission of these strains between Swiss citizens resident
in Geneva, and previous work that the majority of these
strains have not been reported previously in Switzerland [7],
we believe that there is evidence supporting origins of the
isolates from outside Geneva. Although the 99 isolates in
the Geneva University Hospitals collection had diverse
worldwide origins, the majority of the isolates originated
in Europe or Africa, and there were many countries from
which no isolates were collected. However, Geneva is one
of the most international cities in the world and, consequent-
ly, this unique isolate collection is more diverse than what
may have been collected from a single center elsewhere.
Moreover, for isolates with certain ST, PFGE, and spa types,
less than two isolates were available and were excluded in
our analysis.
The epidemiology of MRSA is complex and evolv-
ing, with multiple factors involved, including bacterial
virulence, host immunity, social habits of the host pop-
ulations, and tremendous variation in local and national
MRSA control guidelines. Overall, our study has
attempted to provide a new perspective on global CA-
MRSA epidemiology by exploring bacterial molecular
characteristics and virulence, suggesting that the total
genomic background rather than any single factor is
the most discriminating factor. This study may also
provide insights for MRSA diagnosis and prevention,
as some molecular characteristics associated with specif-
ic genetic backgrounds are discriminating predictors for
bacterial virulence.
Table 2 Two-factor analysis of variance (ANOVA) to determine the
inter-relationship of two epidemiological/molecular characteristics in
association with nematocidal activities. F-tests and p-values of Factor 2
interacting with Factor 1 are listed in the table. Com/hosp,
community-/hospital-associated; agr, accessory gene regulator;
SCCmec, staphylococcal cassette chromosome mec; spa, Staphylococ-
cus aureus protein; ST, sequence type; PFGE, pulsed-field gel
electrophoresis
Factor2 Factor 1
Com/hosp agr SCCmec spa ST PFGE
Com/hosp F09.498, p<0.001 F01.567, p00.215 F01.172, p00.286 F05.735, p00.020 F01.145, p00.291
agr F02.357, p00.077 F01.346, p00.265 F00.044, p00.957 F00.342, p00.712 F00.378, p00.687
SCCmec F03.051, p00.007 F03.157, p00.005 F05.433, p00.001 F03.524, p00.004 F03.846, p00.003
spa F01.555, p00.173 F01.614, p00.052 F02.151, p00.006 F02.408, p00.003 F01.960, p00.025
ST F05.237, p<0.001 F03.207, p<0.001 F04.338, p<0.001 F06.607, p<0.001 F01.848, p00.071
PFGE F01.233, p00.304 F02.177, p00.007 F03.369, p<0.001 F02.930, p00.008 F01.205, p00.289
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